Cargando…
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
The purpose of the study was to determine the long-term safety and effectiveness of high-dose immunosuppressive therapy (HDIT) followed by autologous hematopoietic cell transplantation (AHCT) in advanced multiple sclerosis (MS). Total body irradiation, cyclophosphamide, and antithymocyte globulin we...
Autores principales: | Bowen, James D., Kraft, George H., Wundes, Annette, Guan, QingYan, Maravilla, Kenneth R., Gooley, Theodore A., McSweeney, Peter A., Pavletic, Steven Z., Openshaw, Harry, Storb, Rainer, Wener, Mark, McLaughlin, Bernadette A., Henstorf, Gretchen R., Nash, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276694/ https://www.ncbi.nlm.nih.gov/pubmed/22056644 http://dx.doi.org/10.1038/bmt.2011.208 |
Ejemplares similares
-
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
por: Nash, Richard A., et al.
Publicado: (2017) -
Remission of severe myasthenia gravis after autologous stem cell transplantation
por: Schlatter, Monica I., et al.
Publicado: (2023) -
Treatment for pulmonary manifestations of juvenile systemic sclerosis
por: Henstorf, Gretchen, et al.
Publicado: (2012) -
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019) -
Use of Autologous Blood Components in Lymphedema Treatment: A Systematic Review
por: Forte, Antonio J, et al.
Publicado: (2019)